Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow T2 Biosystems, Inc.

Get SEC filing alerts via email and in your feed for T2 Biosystems, Inc.

TTOO

T2 Biosystems, Inc.

About T2 Biosystems, Inc.

T2 Biosystems specializes in in vitro diagnostics for rapid detection of sepsis-causing pathogens, antibiotic resistance genes, and biothreat agents. Its FDA- and CE-marked products include the T2Dx Instrument and panels for bacteria, fungi, resistance genes, and biothreats, enabling results in hours from unpurified samples. The company targets healthcare, biodefense, and infectious disease markets, emphasizing early diagnosis, improved patient outcomes, and healthcare cost reduction through innovative, easy-to-use molecular testing solutions.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from T2 Biosystems, Inc.

1
1
T2 Biosystems, Inc. T2 Biosystems Reports Mixed Financial Results, Raises Concerns Over Going Concern and Nasdaq Compliance

Via official filing (AI summary) | over 1 year ago | 0 comments